In focus · trending topic

sanfilipposyndrome

20 stories · following the connections

Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in Shanghai

By Nasdaq OMXMar 3, 2017, 12:44 PM UTC

Abeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at the 13th Annual WORLDSymposium™ 2017

By Nasdaq OMXFeb 17, 2017, 12:45 PM UTC

Abeona Therapeutics Announces Presentations and Posters at the 13th Annual WORLDSymposium™ 2017

By Nasdaq OMXFeb 7, 2017, 12:45 PM UTC

Abeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type A

By Nasdaq OMXFeb 1, 2017, 12:43 PM UTC